The conversion rate of tuberculosis screening tests during biological therapies in patients with rheumatoid arthritis.

about

Serial Tuberculosis screening in inflammatory bowel disease patients under anti-TNFα therapy.Severe bacterial sepsis results in delayed diagnosis of tuberculous lymphadenitis in a rheumatoid arthritis patient treated with adalimumab.

P2860

Q40176122-5F7B0F36-2CD8-42CD-B051-6E23224CAB78 Q55253008-B1CE5421-8C2E-4DD7-BC20-4115A6E7B4A7

P2860

The conversion rate of tuberculosis screening tests during biological therapies in patients with rheumatoid arthritis.

Item

http://www.wikidata.org/entity/Q40462327

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The conversion rate of tubercu ...... nts with rheumatoid arthritis.

@en

type

Item

label

The conversion rate of tubercu ...... nts with rheumatoid arthritis.

@en

prefLabel

The conversion rate of tubercu ...... nts with rheumatoid arthritis.

@en

P1476

The conversion rate of tubercu ...... ents with rheumatoid arthritis

@en

P2093

Daniela Iacono

http://www.w3.org/2001/XMLSchema#string

Ilenia Pantano

http://www.w3.org/2001/XMLSchema#string

Virginia D’Abrosca

http://www.w3.org/2001/XMLSchema#string

P2860

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies

Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy.

Challenges in diagnosing latent tuberculosis infection in patients treated with tumor necrosis factor antagonists.

Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: a prospective, observational study.

Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy.

Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.

Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists.

Biphasic emergence of active tuberculosis in rheumatoid arthritis patients receiving TNFα inhibitors: the utility of IFNγ assay.

Granulomatous infectious diseases associated with tumor necrosis factor antagonists.

P304

457-461

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10067-016-3462-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Giovanna Cuomo

P577

2016-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27817127

http://www.w3.org/2001/XMLSchema#string

The conversion rate of tuberculosis screening tests during biological therapies in patients with rheumatoid arthritis.

about

P2860

P2860

The conversion rate of tuberculosis screening tests during biological therapies in patients with rheumatoid arthritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698